Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Function Impairment in Healthy Volunteers”

83 trials

Showing 20 of 83 results

Early research (Phase 1)Looking for participantsNCT07443059
What this trial is testing

Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants

Who this might be right for
Overweight , Obesity
Beijing QL Biopharmaceutical Co.,Ltd 40
Early research (Phase 1)Study completedNCT05404542
What this trial is testing

To Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal Function

Who this might be right for
Renal Impairment
Cerevel Therapeutics, LLC 14
Early research (Phase 1)Study completedNCT07070375
What this trial is testing

Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal Function

Who this might be right for
Gram-negative Bacterial Infections
Jiangsu HengRui Medicine Co., Ltd. 33
Early research (Phase 1)Study completedNCT07032272
What this trial is testing

Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.

Who this might be right for
Autoimmune and Chronic Inflammatory Diseases
Novartis Pharmaceuticals 16
Early research (Phase 1)Study completedNCT02852239
What this trial is testing

Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 22
Early research (Phase 1)Study completedNCT02399202
What this trial is testing

A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 15
Early research (Phase 1)Study completedNCT05618314
What this trial is testing

Study of AT-527 in Subjects With Normal and Impaired Renal Function

Who this might be right for
Healthy VolunteerRenal Impairment
Atea Pharmaceuticals, Inc. 36
Early research (Phase 1)Study completedNCT06190678
What this trial is testing

Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy Participants

Who this might be right for
HealthyRenal Insufficiency
Eli Lilly and Company 16
Early research (Phase 1)Ended earlyNCT00785551
What this trial is testing

Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment

Who this might be right for
HealthyRenal Impairment
Mutual Pharmaceutical Company, Inc. 5
Early research (Phase 1)Study completedNCT03192111
What this trial is testing

Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal ImpairmentHealthy Volunteer
Syndax Pharmaceuticals 40
Early research (Phase 1)Active Not RecruitingNCT07168356
What this trial is testing

Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

Who this might be right for
Hepatitis B
GlaxoSmithKline 32
Early research (Phase 1)Not Yet RecruitingNCT07559240
What this trial is testing

A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy Participants

Who this might be right for
OverweightObese
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 30
Early research (Phase 1)Study completedNCT06929156
What this trial is testing

BGM0504 in Healthy Participants and Participants With Impaired Renal Function

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Overweight or Obese
BrightGene Bio-Medical Technology Co., Ltd. 34
Early research (Phase 1)Study completedNCT03443063
What this trial is testing

Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment

Who this might be right for
Renal Impairment
Eisai Inc. 16
Early research (Phase 1)Study completedNCT01302028
What this trial is testing

Renal Impairment Study With ASP1941

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 40
Early research (Phase 1)Study completedNCT04260464
What this trial is testing

Renal Impairment Study of PF-06700841

Who this might be right for
Healthy VolunteerRenal Impairment
Pfizer 30
Early research (Phase 1)WithdrawnNCT03545087
What this trial is testing

Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants

Who this might be right for
Renal Insufficiency
Eli Lilly and Company
Early research (Phase 1)Study completedNCT03961932
What this trial is testing

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal ImpairmentHealthy Participants
ObsEva SA 33
Early research (Phase 1)Study completedNCT03844555
What this trial is testing

Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients

Who this might be right for
Renal ImpairmentRenal InsufficiencyKidney Diseases+1 more
Genfit 23
Early research (Phase 1)Ended earlyNCT01675973
What this trial is testing

Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine

Who this might be right for
Severe Renal Impairment
Gilead Sciences 4
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation